HIF-1α suppresses transcription of MHC class I heavy chains and antigen-processing components like TAP1/2 and LMP7, reducing surface presentation of tumour antigens [112], leading to diminished CD8+ T cell infiltration and impaired cytotoxic responses. The gene discussed is HIF1A; the disease is neoplasm.